Estrogen Receptor β lpar;ESR2) Polymorphisms and Endometrial Cancer (United States)

2004 ◽  
Vol 15 (6) ◽  
pp. 627-633 ◽  
Author(s):  
Veronica Wendy Setiawan ◽  
Susan E.Hankinson ◽  
Graham A.Colditz ◽  
David J.Hunter ◽  
Immaculata De Vivo
2013 ◽  
Vol 2013 ◽  
pp. 1-5 ◽  
Author(s):  
Kimberly K. Leslie ◽  
Kristina W. Thiel ◽  
Henry D. Reyes ◽  
Shujie Yang ◽  
Yuping Zhang ◽  
...  

Endometrial cancer, the most common gynecologic malignancy in the United States, is on the rise, and survival is worse today than 40 years ago. In order to improve the outcomes, better biomarkers that direct the choice of therapy are urgently needed. In this review, we explore the estrogen receptor as the most studied biomarker and the best predictor for response for endometrial cancer reported to date.


2013 ◽  
Vol 289 (3) ◽  
pp. 631-635 ◽  
Author(s):  
Claus Lattrich ◽  
Julia Häring ◽  
Susanne Schüler ◽  
Maciej Skrzypczak ◽  
Olaf Ortmann ◽  
...  

2016 ◽  
Vol 76 (10) ◽  
Author(s):  
M Kasoha ◽  
C Dernektsi ◽  
R Bohle ◽  
C Zaharia ◽  
EF Solomayer ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 429-429
Author(s):  
Masayoshi Nomura ◽  
Naohiro Fujimoto ◽  
Donald W. Pfaff ◽  
Sonoko Ogawa ◽  
Tetsuro Matsumoto

2004 ◽  
Vol 171 (4S) ◽  
pp. 348-348
Author(s):  
Ellen Shapiro ◽  
Hongying Huang ◽  
Rachael R. Mash ◽  
Eliza Ng ◽  
Deborah E. McFadden ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document